Benjamin J. Schladweiler

John C. Phillips, Jr.

David A. Bilson

Gurpreet S. Walia

Joseph Schramm, III

Gongjun Ji

Jack B. Blumenfeld

Derek J. Fahnestock

Dominick A. Conde

William E. Solander

Michael E. Furrow

Whitney Howard

Erin J. D. Austin

Gregory J. Manas

Madhundra Sivakumar

ANDA filing triggers Xtandi® patent suit. Astellas accuses Aurobindo's generic of infringing its enzalutamide `compound` and cancer treatment method claims.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Judge	Period	PO Win Rate
Colm F. Connolly	09/20/18 - 09/06/19	43%
Gregory M. Sleet	05/23/18 - 09/20/18	49%

Name	Ratings
Astellas Pharma US Inc NPE	L3 A
Medivation Prostate Therapeutics LLC	L5 A
Medivation LLC	L5 A
Regents of University of California NPE	L3 A
Astellas US LLC NPE	L3 A

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jack B. Blumenfeld	L5 A
Derek J. Fahnestock	L5 A
Fitzpatrick Cella Harper & Scinto	L4 A
Dominick A. Conde	L5 A
William E. Solander	L4 A
Michael E. Furrow	L1 B
Erin J. D. Austin	-- -- --
Venable LLP	L4 A
Whitney Howard	L1 C
Gregory J. Manas	-- -- --
Ballard Spahr LLP	L3 B
Madhundra Sivakumar	-- -- --

Name	Ratings
Eugia Pharma Specialities Ltd	L3 E
Aurobindo Pharma USA Inc	L3 E

Name	Ratings
Greenberg Traurig LLP	L5 D
Benjamin J. Schladweiler	L1 D
Phillips Goldman McLaughlin & Hall PALocal	L4 E
John C. Phillips, Jr.	L5 E
David A. Bilson	L5 E
Fisherbroyles LLP	L1 E
Gongjun Ji	L1 B
Joseph Schramm, III	L1 D
Gurpreet S. Walia	L1 D

1:18-cv-00757

Astellas Pharma Inc v. Eugia Pharma Specialities Ltd